KDELR1

ER lumen protein-retaining receptor 1 · P24390 · KDELR1 on Sugi Atlas →

0 patent compounds predicted against KDELR1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to KDELR1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Does Aldosterone Cause Hypertension by a Non-Renal Mechanism? PHASE4UNKNOWN
Effects of Liraglutide on ER Stress in Obese Patients With Type 2 Diabetes PHASE4UNKNOWN
Ambroxol Therapy for Patients With Type 1 Gaucher Disease and Suboptimal Response to Enzyme Replacement Therapy PHASE2COMPLETED
Targeting Endoplasmic Reticulum Stress in Human Hypertension PHASE1/PHASE2RECRUITING
CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops PHASE2UNKNOWN
Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity PHASE2RECRUITING
A Study Evaluating Megestrol Acetate Modulation in Hormone Receptor Positive Advanced Breast Cancer PHASE2UNKNOWN
Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer PHASE2WITHDRAWN
Phase I Study of Novel Estrogen Receptor(ER) a36 Modifier Icaritin in Advanced Breast Cancer Patients PHASE1UNKNOWN
A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors PHASE1COMPLETED
Tamoxifen in Patients With Oesophageal Cancer PHASE1UNKNOWN
Choline Effects - Pre-symptomatic AD PHASE1COMPLETED
PBA Use for Treatment of ATF6-/- Patients EARLY_PHASE1SUSPENDED
Bristol-Myers Squibb Dasatinib Src Inhibition in Endometrial Cancer EARLY_PHASE1COMPLETED
Quantification of GADD34 Expression in RA nanCOMPLETED
Immunological Profile and Clinical Characteristics of Children Diagnosed With Chronic Granulomatous Disease nanUNKNOWN
Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders nanUNKNOWN
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Fatty Acids Lipidome and Oxidative Stress in Liver Transplantation nanUNKNOWN
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
FESPET Study: Female EStrogen recePtor in Endometrial Cancer Treatment nanUNKNOWN
MERC Proteins in Saliva and GCF in Periodontal Disease (ELISA Study) nanCOMPLETED
Clinical and Basic Research on the Necessity of Scar Tissue Resection During Intrauterine Adhesions nanUNKNOWN
Association Between Luminal Bile Salt Content and Duodenal Mucosal Integrity in Functional Dyspepsia nanCOMPLETED
for Adipose Tissue DIabetes VAriants (fATDIVA) nanCOMPLETED
sCD163 in ALS Patients nanCOMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Neutrophils as Prognostic Factors in Granulomatosis With Polyangiitis (Formerly Named Wegener's Granulomatosis) nanCOMPLETED
Phenotypic and Genotypic Characterization of Subjects With Syndromic Obesity: Identifying New Candidate Genes by Exome Sequencing (OBEXOME) nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a KDELR1 binder may also engage these)

ProteinNameSimilarity
Q6P257 1.000 Q6P257 →
Q2KJ37 1.000 Q2KJ37 →
Q99JH8 1.000 Q99JH8 →
P33946 1.000 P33946 →
KDELR2 ER lumen protein-retaining receptor 2 1.000 landscape →
Q569A6 1.000 Q569A6 →
Q5XHA2 1.000 Q5XHA2 →
Q66JF2 1.000 Q66JF2 →
Q8R1L4 1.000 Q8R1L4 →
Q6PAB8 1.000 Q6PAB8 →
Q7ZXS5 1.000 Q7ZXS5 →
Q9CQM2 1.000 Q9CQM2 →
Q6PEH1 1.000 Q6PEH1 →
Q9ZTN2 1.000 Q9ZTN2 →
Q5U305 1.000 Q5U305 →
Q6PFS5 1.000 Q6PFS5 →
Q5ZKX9 1.000 Q5ZKX9 →
Q68ES4 1.000 Q68ES4 →
O43731 1.000 O43731 →
Q8VWI1 1.000 Q8VWI1 →
Q611C8 0.999 Q611C8 →
O76767 0.999 O76767 →
P48583 0.999 P48583 →
Q09473 0.998 Q09473 →
O42580 0.998 O42580 →
P35402 0.998 P35402 →
Q76NM1 0.993 Q76NM1 →
P33948 0.991 P33948 →
P18414 0.989 P18414 →
O44017 0.988 O44017 →